tradingkey.logo

tradingkey.logo
怜玢


Pacific Biosciences of California Inc

PACB
りォッチリストに远加
2.900USD
+0.070+2.47%
終倀 10-29 16:00ET
901.41M時䟡総額
損倱額盎近12ヶ月PER

Pacific Biosciences of California Incに぀いお 䌁業名

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

Pacific Biosciences of California Inc プロフィヌル


䌁業コヌドPACB
䌚瀟名Pacific Biosciences of California Inc
䞊堎日Oct 27, 2010
最高経営責任者「CEO」Henry (Christian O)
埓業員数575
蚌刞皮類Ordinary Share
決算期末Oct 27
本瀟所圚地1305 O'brien Drive
郜垂MENLO PARK
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94025
電話番号16505218000
りェブサむトhttps://www.pacb.com/
䌁業コヌドPACB
䞊堎日Oct 27, 2010
最高経営責任者「CEO」Henry (Christian O)

Pacific Biosciences of California Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Christian O. Henry
Mr. Christian O. Henry
Director
Director
1.25M
+9.33%
Mr. Christian O. Henry
Mr. Christian O. Henry
Director
Director
1.25M
+9.33%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
132.82K
+17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
132.82K
+17.18%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
132.82K
+17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
132.82K
+17.18%
Dr. Christopher (Chris) Gibson, Ph.D.
Dr. Christopher (Chris) Gibson, Ph.D.
Director
Director
111.39K
+51.60%
Dr. Christopher (Chris) Gibson, Ph.D.
Dr. Christopher (Chris) Gibson, Ph.D.
Director
Director
111.39K
+51.60%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Christian O. Henry
Mr. Christian O. Henry
Director
Director
1.25M
+9.33%
Mr. Christian O. Henry
Mr. Christian O. Henry
Director
Director
1.25M
+9.33%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
132.82K
+17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
132.82K
+17.18%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
132.82K
+17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
132.82K
+17.18%

よくある質問

Pacific Biosciences of California Incの䞊䜍5名の株䞻は誰ですか


Pacific Biosciences of California Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Christian O. Henry

Pacific Biosciences of California IncPACBの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Pacific Biosciences of California Incの株匏を保有しおいる機関は540瀟あり、保有株匏の総垂堎䟡倀は玄192.85Mで、党䜓の62.12%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-19483139.00増加しおいたす。

Pacific Biosciences of California Incの最倧の収益源は䜕ですか


2026Q1においお、Consumable revenue郚門がPacific Biosciences of California Incにずっお最倧の収益を生み出しおおり、その金額は20.11Mで、党収益の51.56%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。